Bacterial vaginosis among women at high risk for HIV in Uganda: High rate of recurrent diagnosis despite treatment

Sexually Transmitted Infections

Volumn 92, Issue 2, 2016, Pages 142-148

  Francis, Suzanna C ^a   Looker, Clare ^a   Vandepitte, Judith ^b   Bukenya, Justine ^b   Mayanja, Yunia ^b   Nakubulwa, Susan ^b   Hughes, Peter ^b   Hayes, Richard J ^a   Weiss, Helen A ^a   Grosskurth, Heiner ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONDOM USE; DYSPAREUNIA; DYSURIA; FEMALE; FOLLOW UP; GENITAL PRURITUS; GENITAL ULCER; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; RECURRENT INFECTION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SURVIVAL; TREATMENT DURATION; UGANDA; VAGINA DISCHARGE; VAGINA SMEAR; VAGINAL BURNING SENSATION; VAGINITIS; ADOLESCENT; HIV INFECTIONS; MICROBIOLOGY; MIDDLE AGED; RECURRENT DISEASE; RISK FACTOR; SEX WORKER; TRANSMISSION; VAGINA; VAGINOSIS, BACTERIAL;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MIDDLE AGED; PREVALENCE; RECURRENCE; RISK FACTORS; SEX WORKERS; SEXUAL PARTNERS; UGANDA; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84958926942     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2015-052160     Document Type: Article

References (32)

1. Low N, Chersich MF, Schmidlin K, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: Individual participant data meta-analysis. PLoS Med 2011;8:e1000416.
2. Leitich H, Bodneradler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: A meta-analysis. Am J Obstet Gynecol 2003;189:139-47.
3. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996;175:435-41.
4. Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003;37:319-25.
5. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003;36:663-8.
6. Balkus JE, Richardson BA, Rabe LK, et al. Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women. Sex Transm Dis 2014;41:123-8.
7. Cu-Uvin S, Hogan JW, Caliendo AM, et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001;33:894-6.
8. Cherpes TL, Melan MA, Kant JA, et al. Genital tract shedding of herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005;40:1422-8.
9. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22. http://www. ncbi.nlm.nih.gov/pubmed/6600371 (accessed 22 Aug 2011).
10. Mlisana K, Naicker N, Werner L, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012;206:6-14.
11. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110. http://www.ncbi.nlm.nih.gov/pubmed/21160459 (accessed 3 Jan 2014).
12. Sherrard J, Donders G, White D, et al. European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. Int J STD AIDS 2011;22:421-9.
13. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva: WHO, 2003.
14. Bradshaw CS, Morton AN, Hocking JS, et al. High recurrence rates of bacterial vaginosis over the course of 12months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-86.
15. Myer L, Kuhn L, Denny L, et al. Recurrence of symptomatic bacterial vaginosis 12months after oral metronidazole therapy in HIV-positive and-negative women. J Infect Dis 2006;194:1797-9.
16. Vandepitte J, Weiss HA, Bukenya J, et al. Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda. J Acquir Immune Defic Syndr 2013;62:119-26.
17. Ministry of Health. Uganda clinical guidelines: National Guidelines on Management of Common Conditions. Kampala, Uganda, 2010.
18. Nugent RP, Krohn MA, Hillier SL, et al. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301. http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=269757&tool=pmcentrez&rendertype=abstract
19. Victora CG, Huttly SR, Fuchs SC, et al. The role of conceptual frameworks in epidemiological analysis: A hierarchical approach. Int J Epidemiol 1997;26:224-7.
20. Ramjee G, Karim SS, Sturm AW. Sexually transmitted infections among sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis 1998;25:346-9. http://www.ncbi. nlm.nih.gov/pubmed/9713913 (accessed 8 Nov 2011).
21. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-8.
22. Graver MA, Wade JJ. The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann Clin Microbiol Antimicrob 2011;10:8.
23. Gong Z, Luna Y, Yu P, et al. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS ONE 2014;9:e107758.
24. Conti C, Malacrino C, Mastromarino P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 2009;60(Suppl 6):19-26.
25. Lai SK, Hida K, Shukair S, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 2009;83:11196-200.
26. Mitchell C, Marrazzo J. Bacterial Vaginosis and the Cervicovaginal Immune Response. Am J Reprod Immunol 2014;71:555-63.
27. Swedberg J, Steiner JF, Deiss F, et al. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA 1985;254: 1046-9.http://www.ncbi.nlm.nih.gov/pubmed/3894707 (accessed 7 Mar 2014).
28. Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: A synthesis of data. Clin Infect Dis 2002;35:S152-72.
29. Srinivasan S, Hoffman NG, Morgan MT, et al. Bacterial communities in women with bacterial vaginosis: High resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 2012;7:e37818.
30. Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: A systematic review and meta-analysis. PLoS ONE 2013;8:e73055.
31. Morrison CS, Chen PL, Kwok C, et al. Hormonal contraception and the risk of HIV acquisition: An individual participant data meta-analysis. PLoS Medicine 2015;21(1). doi:10.1371/journal.pmed.1001778.
32. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 2010;5:e10197.